Open Access

Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9

  • Authors:
    • Thuy Nguyen Thi
    • Hien Duong Thanh
    • Van-Tan Nguyen
    • Se-Young Kwon
    • Changjong Moon
    • Eu Chang Hwang
    • Chaeyong Jung
  • View Affiliations

  • Published online on: May 31, 2024     https://doi.org/10.3892/ijo.2024.5659
  • Article Number: 71
  • Copyright: © Thi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

CD46, a transmembrane protein known for protecting cells from complement‑mediated damage, is frequently dysregulated in various types of cancer. Its overexpression in bladder cancers safeguards the cancer cells against both complement and antibody‑mediated cytotoxicity. The present study explored a new role of CD46 in facilitating cancer cell invasion and metastasis, examining its regulatory effect on matrix metalloproteases (MMPs) and their effect on the metastatic capability of bladder cancer cells. Specifically, CD46 alteration positively influenced MMP9 expression, but not MMP2, in several bladder cancer cell lines. Furthermore, CD46 overexpression triggered phosphorylation of p38 MAPK and protein kinase B (AKT), leading to enhanced activator protein 1 (AP‑1) activity via c‑Jun upregulation. The inhibition of p38 or AKT pathways attenuated the CD46‑induced MMP9 and AP‑1 upregulation, indicating that the promotion of MMP9 by CD46 involved activating both p38 MAPK and AKT. Functionally, the upregulation of MMP9 by CD46 translated to increased migratory and invasive capabilities of bladder cancer cells, as well as enhanced in vivo metastasis. Overall, the present study revealed a novel role for CD46 as a metastasis promoter through MMP9 activation in bladder cancers and highlighted the regulatory mechanism of CD46‑mediated MMP9 promotion via p38 MAPK and AKT activation.
View Figures
View References

Related Articles

Journal Cover

July-2024
Volume 65 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Thi TN, Thanh HD, Nguyen V, Kwon S, Moon C, Hwang EC and Jung C: Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9. Int J Oncol 65: 71, 2024.
APA
Thi, T.N., Thanh, H.D., Nguyen, V., Kwon, S., Moon, C., Hwang, E.C., & Jung, C. (2024). Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9. International Journal of Oncology, 65, 71. https://doi.org/10.3892/ijo.2024.5659
MLA
Thi, T. N., Thanh, H. D., Nguyen, V., Kwon, S., Moon, C., Hwang, E. C., Jung, C."Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9". International Journal of Oncology 65.1 (2024): 71.
Chicago
Thi, T. N., Thanh, H. D., Nguyen, V., Kwon, S., Moon, C., Hwang, E. C., Jung, C."Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9". International Journal of Oncology 65, no. 1 (2024): 71. https://doi.org/10.3892/ijo.2024.5659